[144] Johnson Controls International plc SEC Filing

Rhea-AI Filing Summary

Johnson Controls International plc (JCI) notice indicates an intended sale of 4,266 common shares via Morgan Stanley Smith Barney with an aggregate market value of $455,992.74, to be sold on 09/02/2025 on the NYSE. The shares were acquired as restricted stock units on 12/15/2023. The filing reports prior Rule 10b5-1 sales by the same holder of 1,422 shares on 07/01/2025 and 08/01/2025, generating gross proceeds of $149,054.32 and $147,447.18, respectively. The total number of shares outstanding listed is 654,385,440. The filer affirms no undisclosed material adverse information and references compliance with Rule 144 and 10b5-1 procedures.

Positive

• Detailed disclosure of proposed sale including broker, share count, market value, and exchange
• Identification of acquisition nature and date (Restricted Stock Units acquired 12/15/2023)
• Reporting of prior Rule 10b5-1 sales with dates and gross proceeds, indicating procedural transparency
• Seller's certification that no undisclosed material adverse information is known

Negative

• None.

Insights

Securities Analyst

TL;DR Small planned sale of RSU shares under Rule 144 with prior 10b5-1 transactions; appears procedural and non-material to equity base.

The filing details a proposed sale of 4,266 common shares acquired as restricted stock units and scheduled via a broker on the NYSE. Prior 10b5-1 sales of 1,422 shares each in July and August 2025 are reported with gross proceeds provided. Relative to the reported outstanding share count of 654,385,440, the amounts are immaterial to capitalization. The filing emphasizes Rule 144 procedural compliance and the seller's representation of no undisclosed material adverse information. For investors, this reads as routine insider liquidity rather than a signal of company operational change.

Corporate Governance Expert

TL;DR Disclosure follows standard Rule 144 and 10b5-1 practice; documentation supports governance transparency.

The notice specifies the acquisition date, nature of acquisition (RSUs), broker details, and aggregation of recent 10b5-1 sales. Inclusion of the seller's certification regarding material information and the plan-adoption fields aligns with best practices for insider trading compliance. The clear record of prior programmed sales and transaction specifics enhances disclosure quality from a governance standpoint. No governance red flags are evident within the content provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4266	455992.74	654385440	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2023	Restricted Stock Units	Issuer			4266	12/15/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NATHAN D MANNING One Albert Quay Cork L2 T12 X8N6	Common	08/01/2025	1422	147447.18
10b5-1 Sales for NATHAN D MANNING One Albert Quay Cork L2 T12 X8N6	Common	07/01/2025	1422	149054.32

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the JCI Form 144 propose to sell?

The notice proposes sale of 4,266 shares of common stock.

What is the aggregate market value of the shares proposed for sale in the JCI filing?

The aggregate market value reported is $455,992.74.

When were the shares being sold acquired according to the filing?

The shares were acquired as restricted stock units on 12/15/2023.

Were there recent 10b5-1 sales reported for the same account?

Yes. The filing reports 10b5-1 sales of 1,422 shares on 07/01/2025 (proceeds $149,054.32) and 08/01/2025 (proceeds $147,447.18).

Through which broker will the proposed sale be executed?

The broker listed is Morgan Stanley Smith Barney LLC.